Monoamine oxidase inhibitors attenuate cytotoxicity of 1-methyl-4-phenylpyridinium by suppressing mitochondrial permeability transition

Korean Journal of Physiology and Pharmacology

Volumn 10, Issue 4, 2006, Pages 207-212

  Lee, Chung Soo ^a  

^a Chung Ang University   (South Korea)

Author keywords

Cell death; Mitochondrial permeability transition; Monoamine oxidase inhibitors; MPP+; Preventive effect

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; AMINE OXIDASE (FLAVIN CONTAINING); CASPASE 3; CLORGYLINE; CYTOCHROME C; GLUTATHIONE; MONOAMINE OXIDASE INHIBITOR; REACTIVE OXYGEN METABOLITE; SELEGILINE; TRANYLCYPROMINE;

ANIMAL CELL; ARTICLE; CELL STRAIN; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG POTENCY; ENZYME INHIBITION; ENZYME RELEASE; INHIBITION KINETICS; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OXIDATIVE STRESS; RAT;

EID: 33748611368     PISSN: 12264512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Andoh T, Chock PB, Murphy DL, Chiueh CC. Role of the redox protein thioredox in cytoprotective mechanism evoked by (-)-deprenyl. Mol Pharmacol 68: 1408-1414, 2005
2. Birkmayer W, Knoll J, Riederer P, Youdim MB, Hars V, Marton J. Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study. J Neural Transm 64: 113-127, 1985
3. + opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim Biophys Acta 1453: 49-62, 1999
4. Chandra J, Samali A, Orrenius S. Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med 29: 323-333, 2000
5. Constantini PC, Chernyak BC, Petronilli V, Bernardi P. Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J Biol Chem 271: 6746-6751, 1996
6. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 341: 233-249, 1999
7. Crow MT, Mani K, Nam Y-J, Kitsis RN. The mitochondrial death pathway and cardiac myocyte apoptosis. Circ Res 95: 957-970, 2004
8. + and MPTP in PC12 cells independent of reactive oxygen species formation. Brain Res 905: 199-206, 2001
9. Fu W, Luo H, Parthasarathy S, Mattson MP. Catecholamines potentiate amyloid β-peptide neurotoxicity: involvement of oxidative stress, mitochondrial dysfunction, and perturbed calcium homeostasis. Neurobiol Dis 5: 229-243, 1998
10. Hall AG. The role of glutathione in the regulation of apoptosis. Eur J Clin Invest 29: 238-245, 1999
11. Kadota T, Yamaai T, Saito Y, Akita Y, Kawashima S, Moroi K, Inagaki N, Kadota K. Expression of dopamine transporter at the tips of growing neurites of PC12 cells. J Histochem Cytochem 44: 989-996, 1996
12. Kim R, Emi M, Tanabe K. Role of mitochondria as the gardens of cell death. Cancer Chemother Pharmacol 57: 545-553, 2006
13. Lai C-T, Yu PH. Dopamine- and L-β-3,4-dihydroxyphenylalanine hydrochloride (L-DOPA)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors. Biochem Pharmacol 53: 363-372, 1997
14. +)-induced apoptosis independent of MAO-B inhibition. Neurosci Lett 224: 197-200, 1997
15. Lee CS, Han ES, Jang YY, Han JH, Ha HW, Kim DE. Protective effect of harmalol and harmaline on MPTP neurotoxicity in the mouse and dopamine-induced damage of brain mitochondria and PC12 Cells. J Neurochem 75: 521-531, 2000
16. + on membrane permeability in brain mitochondria and cell viability in PC12 cells. Neurochem Int 40: 361-369, 2002
17. +-induced mitochondrial damage and cell death by trifluoperazine and W-7 in PC12 cells. Neurochem Int 46; 169-178, 2005
18. Lotharius J, Dugan LL, O'Malley KL. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J Neurosci 19: 1284-1293, 1999
19. Maher P, Davis JB. The role of monoamine metabolism in oxidative glutamate toxicity. Neuroscience 16: 6394-6401, 1996
20. Marcocci L, De Marchi U, Salvi M, Milella ZG, Nocera S, Agostinelli E, Mondovi B, Toninello A. Tyramine and monoamine oxidase inhibitors as modulators of the mitochondrial membrane permeability transition. J Membr Biol 188: 23-31, 2002
21. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983
22. Obata T. Dopamine efflux by MPTP and hydroxyl radical generation. J Neural Transm 109: 1159-1180, 2002
23. + administration to mice. Pharamcol Toxicol 72: 364-368, 1993
24. Tan S, Sagara Y, Liu Y, Maher P, Schubert D. The regulation of reactive oxygen species production during programmed cell death. J Cell Biol 141: 1423 -1432, 1998
25. Tatton WG, Chalmers-Redman RME. Modulation of gene expression rather than monoamine oxidase inhibition. Neurology 47(Suppl. 3): S171-S183, 1996
26. Tatton WG, Chalmers-Redman RME, Ju WJH. Mammen M, Carlile GW, Pong AW, Tatton NA. Propargylamines induce antiapoptotic new protein synthesis in serum- and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells. J Pharmacol Exp Ther 301: 753-764, 2002
27. Tatton WG, Chalmers-Redman RME, Tatton NA. Neuroprotection by deprenyl and other propargylamines: glyceraldehydes-3-phosphate dehydrogenase rather than monoamine oxidase B. J Neural Transm 110: 509-515, 2003
28. Vaglini F, Pardini C, Cavalletti M, Maggio R, Corsini GU. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion. Brain Res 741: 68-74, 1996
29. van Klaveren RJ, Hoet PH, Pype JL, Demedts M, Nemery B. Increase in gamma-glutamyltransferase by glutathione depletion in rat type II pneumocytes. Free Radic Biol Med 22: 525-534, 1997
30. + toxicity in Vivo. Ann NY Acad Sci 899: 255-261, 2000
31. Yi H, Akao Y, Maruyama W, Chen K, Shih J, Naoi M. Type A monoamine oxidase is the target of an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol, leading to apoptosis to apoptosis in SH-SY5Y cells. J Neurochem 96: 541-549, 2006